Additional Benefits of Retatrutide In addition to significant weight loss, Retatrutide has shown promise in improving metabolic dysfunction-associated steatohepatitis (MASLD)
Livadas S, Pappas C, Karachalios A, Marinakis E, Tolia N, Drakou M (2014) Prevalence and impact of hyperandrogenemia in 1218 women with polycystic ovary syndrome
Patients can also choose oral formulations of either medication, with oral tirzepatide at $349/mo month-to-month, or from $279/mo on the 6-month plan and oral semaglutide at $289/mo (or $249/mo on the 6-month plan)
An alternative, nonapoptotic form of programmed cell death
Some other factors include how well blood sugar levels are controlled, the patient's activity levels, and what else makes up their diet
Safety Comparison Table# Research Evidence Comparison# Amycretin Research# Amycretin has early but impressive data: Phase 1 (SC): Published in The Lancet (2025)